Skip to main content
. 2016 May 19;11(8):1377–1383. doi: 10.2215/CJN.10260915

Table 1.

Descriptive statistics by institution

Characteristic VU, n=14 CCF, n=29 UAB, n=25 Combined, n=68
Antibiotic dose, g
 2 0% (0) 0% (0) 84% (21) 31% (21)
 3 100% (14) 100% (29) 16% (4) 69% (47)
Antibiotic infusion duration, min
 30 0% (0) 100% (29) 100% (25) 79% (54)
 240 100% (14) 0% (0) 0% (0) 21% (14)
Antibiotic frequency, h
 6 0% (0) 3% (1) 96% (24) 37% (25)
 8 79% (11) 76% (22) 4% (1) 50% (34)
 12 21% (3) 21% (6) 0% (0) 13% (9)
CRRT effluent rate, ml/kg per h 30.9 (28.5–33.0) 22.8 (20.8–25.3) 40.0 (28.5–45.5) 26.6 (23.7–37.0)
CRRT mode
 CVVH 36% (5) 0% (0) 0% (0) 7.4% (5)
 CVVHD 0% (0) 100% (29) 0% (0) 42.6% (29)
 CVVHDF 64% (9) 0% (0) 100% (25) 50% (34)
Weight, kg 99.8 (80.8–118.7) 100.8 (90.2–125.5) 88.3 (68.1–105.3) 96.9 (80.8–116.2)
Age, yr 53.5 (47.0–60.5) 64.0 (55.0–72.0) 51.0 (40.0–63.0) 56.5 (50.0–70.0)
Sex
 Women 29% (4) 21% (6) 56% (14) 35% (24)
 Men 71% (10) 79% (23) 44% (11) 65% (44)
Mortality 43% (6) 41% (12) 52% (13) 46% (31)
Piperacillin PK
 V 27.3 (22.7–31.0) 34.4 (30.5–44.1) 33.8 (26.2–40.9) 33.0 (25.7–40.5)
 k 0.151 (0.131–0.177) 0.108 (0.093–0.134) 0.140 (0.130–0.194) 0.132 (0.106–0.153)
Tazobactam PK
 V 34.5 (30.8–39.1) 31.4 (24.7–36.6) 47.8 (39.5–59.0) 36.6 (28.2–46.1)
 k 0.102 (0.094–0.112) 0.079 (0.071–0.091) 0.115 (0.105–0.124) 0.096 (0.080–0.113)

Quantitative values are summarized using medians (interquartile ranges). Categorical variables are summarized using percentages (counts). VU, Vanderbilt University; CCF, Cleveland Clinic Foundation; UAB, University of Alabama at Birmingham; CRRT, continuous RRT; CVVH, continuous venovenous hemofiltration; CVVHD, continuous venovenous hemodialysis; CVVHDF, continuous venovenous hemodiafiltration; PK, pharmacokinetics; V, volume of distribution; k, elimination rate.